Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hedrich

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Pharmacokinetics|December 1, 2017
Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons LearnedWilliam D Hedrich, Tamer E Fandy, Hossam M Ashour, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2011
Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010L Wiessing, G Likatavicius, D Hedrich, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1992
Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipientsD K Jorkasky, P Audet, N Shusterman, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 7, 2013
Human immunodeficiency virus among people who inject drugs: is risk increasing in Europe?D Hedrich, E Kalamara, O Sfetcu, et al.
Molecular Pharmaceutics|January 11, 2017
Microneedle-Assisted Skin Permeation by Nontoxic Bioengineerable Gas Vesicle NanoparticlesAbhay U Andar, Ram Karan, Wolf T Pecher, et al.
Molecular Cancer Therapeutics|January 30, 2016
Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma TreatmentWilliam D Hedrich, Jingwei Xiao, Scott Heyward, et al.
European Journal of Medicinal Chemistry|June 28, 2019
Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapiesDongdong Liang, Linhao Li, Caitlin Lynch, et al.
Toxicology|November 17, 2020
Development and characterization of rat duodenal organoids for ADME and toxicology applicationsWilliam D Hedrich, Julie M Panzica-Kelly, Shen-Jue Chen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2011
Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011A Pharris, L Wiessing, O Sfetcu, et al.
Journal of Medicinal Chemistry|March 27, 2025
Potent and Selective Human Constitutive Androstane Receptor Activator DL5055 Facilitates Cyclophosphamide-Based ChemotherapiesDongdong Liang, Linhao Li, Yong Ai, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Pharmacokinetics|December 1, 2017
Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons LearnedWilliam D Hedrich, Tamer E Fandy, Hossam M Ashour, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2011
Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010L Wiessing, G Likatavicius, D Hedrich, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1992
Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipientsD K Jorkasky, P Audet, N Shusterman, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 7, 2013
Human immunodeficiency virus among people who inject drugs: is risk increasing in Europe?D Hedrich, E Kalamara, O Sfetcu, et al.
Molecular Pharmaceutics|January 11, 2017
Microneedle-Assisted Skin Permeation by Nontoxic Bioengineerable Gas Vesicle NanoparticlesAbhay U Andar, Ram Karan, Wolf T Pecher, et al.
Molecular Cancer Therapeutics|January 30, 2016
Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma TreatmentWilliam D Hedrich, Jingwei Xiao, Scott Heyward, et al.
European Journal of Medicinal Chemistry|June 28, 2019
Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapiesDongdong Liang, Linhao Li, Caitlin Lynch, et al.
Toxicology|November 17, 2020
Development and characterization of rat duodenal organoids for ADME and toxicology applicationsWilliam D Hedrich, Julie M Panzica-Kelly, Shen-Jue Chen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 17, 2011
Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011A Pharris, L Wiessing, O Sfetcu, et al.
Journal of Medicinal Chemistry|March 27, 2025
Potent and Selective Human Constitutive Androstane Receptor Activator DL5055 Facilitates Cyclophosphamide-Based ChemotherapiesDongdong Liang, Linhao Li, Yong Ai, et al.
Pageof 3